vs
Side-by-side financial comparison of PTC THERAPEUTICS, INC. (PTCT) and COMSCORE, INC. (SCOR). Click either name above to swap in a different company.
PTC THERAPEUTICS, INC. is the larger business by last-quarter revenue ($164.7M vs $93.5M, roughly 1.8× COMSCORE, INC.). COMSCORE, INC. runs the higher net margin — 3.2% vs -82.0%, a 85.2% gap on every dollar of revenue. On growth, COMSCORE, INC. posted the faster year-over-year revenue change (-1.5% vs -22.7%). COMSCORE, INC. produced more free cash flow last quarter ($2.9M vs $-36.6M). Over the past eight quarters, COMSCORE, INC.'s revenue compounded faster (3.8% CAGR vs -11.5%).
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
Comscore, Inc. is an American-based global media measurement and analytics company providing marketing data and analytics to enterprises, advertising agencies, brand marketers, and publishers.
PTCT vs SCOR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $164.7M | $93.5M |
| Net Profit | $-135.0M | $3.0M |
| Gross Margin | — | 41.0% |
| Operating Margin | -43.3% | 7.0% |
| Net Margin | -82.0% | 3.2% |
| Revenue YoY | -22.7% | -1.5% |
| Net Profit YoY | -104.8% | -3.7% |
| EPS (diluted) | $-1.63 | $9.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $164.7M | $93.5M | ||
| Q3 25 | $211.0M | $88.9M | ||
| Q2 25 | $178.9M | $89.4M | ||
| Q1 25 | $1.2B | $85.7M | ||
| Q4 24 | $213.2M | $94.9M | ||
| Q3 24 | $196.8M | $88.5M | ||
| Q2 24 | $186.7M | $85.8M | ||
| Q1 24 | $210.1M | $86.8M |
| Q4 25 | $-135.0M | $3.0M | ||
| Q3 25 | $15.9M | $453.0K | ||
| Q2 25 | $-64.8M | $-9.5M | ||
| Q1 25 | $866.6M | $-4.0M | ||
| Q4 24 | $-65.9M | $3.1M | ||
| Q3 24 | $-106.7M | $-60.6M | ||
| Q2 24 | $-99.2M | $-1.7M | ||
| Q1 24 | $-91.6M | $-1.1M |
| Q4 25 | — | 41.0% | ||
| Q3 25 | — | 40.6% | ||
| Q2 25 | — | 40.6% | ||
| Q1 25 | — | 39.6% | ||
| Q4 24 | — | 42.4% | ||
| Q3 24 | — | 41.2% | ||
| Q2 24 | — | 39.5% | ||
| Q1 24 | — | 42.3% |
| Q4 25 | -43.3% | 7.0% | ||
| Q3 25 | 1.4% | 1.9% | ||
| Q2 25 | -19.5% | -1.9% | ||
| Q1 25 | 82.5% | -2.4% | ||
| Q4 24 | -76.2% | 4.1% | ||
| Q3 24 | -27.7% | -67.4% | ||
| Q2 24 | -21.5% | -2.2% | ||
| Q1 24 | -21.6% | -2.2% |
| Q4 25 | -82.0% | 3.2% | ||
| Q3 25 | 7.5% | 0.5% | ||
| Q2 25 | -36.3% | -10.6% | ||
| Q1 25 | 73.7% | -4.7% | ||
| Q4 24 | -30.9% | 3.3% | ||
| Q3 24 | -54.2% | -68.5% | ||
| Q2 24 | -53.1% | -2.0% | ||
| Q1 24 | -43.6% | -1.2% |
| Q4 25 | $-1.63 | $9.50 | ||
| Q3 25 | $0.20 | $-0.86 | ||
| Q2 25 | $-0.83 | $-2.73 | ||
| Q1 25 | $10.04 | $-1.66 | ||
| Q4 24 | $-0.85 | $-0.47 | ||
| Q3 24 | $-1.39 | $-12.79 | ||
| Q2 24 | $-1.29 | $-1.19 | ||
| Q1 24 | $-1.20 | $-1.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.9B | $23.6M |
| Total DebtLower is stronger | — | $41.5M |
| Stockholders' EquityBook value | $-205.3M | $111.4M |
| Total Assets | $2.9B | $407.7M |
| Debt / EquityLower = less leverage | — | 0.37× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.9B | $23.6M | ||
| Q3 25 | $1.7B | $26.7M | ||
| Q2 25 | $2.0B | $26.0M | ||
| Q1 25 | $2.0B | $31.0M | ||
| Q4 24 | $1.1B | $29.9M | ||
| Q3 24 | $1.0B | $20.0M | ||
| Q2 24 | $1.1B | $14.7M | ||
| Q1 24 | $884.8M | $18.7M |
| Q4 25 | — | $41.5M | ||
| Q3 25 | — | $41.4M | ||
| Q2 25 | — | $41.3M | ||
| Q1 25 | — | $41.3M | ||
| Q4 24 | — | $41.2M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $-205.3M | $111.4M | ||
| Q3 25 | $-155.8M | $-26.3M | ||
| Q2 25 | $-206.5M | $-21.7M | ||
| Q1 25 | $-185.8M | $-13.5M | ||
| Q4 24 | $-1.1B | $-8.3M | ||
| Q3 24 | $-1.1B | $-2.7M | ||
| Q2 24 | $-980.2M | $45.8M | ||
| Q1 24 | $-893.9M | $51.4M |
| Q4 25 | $2.9B | $407.7M | ||
| Q3 25 | $2.6B | $406.9M | ||
| Q2 25 | $2.6B | $415.9M | ||
| Q1 25 | $2.7B | $421.5M | ||
| Q4 24 | $1.7B | $430.2M | ||
| Q3 24 | $1.8B | $412.5M | ||
| Q2 24 | $1.9B | $474.1M | ||
| Q1 24 | $1.8B | $477.7M |
| Q4 25 | — | 0.37× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.3M | $3.2M |
| Free Cash FlowOCF − Capex | $-36.6M | $2.9M |
| FCF MarginFCF / Revenue | -22.3% | 3.1% |
| Capex IntensityCapex / Revenue | 1.4% | 0.3% |
| Cash ConversionOCF / Net Profit | — | 1.07× |
| TTM Free Cash FlowTrailing 4 quarters | $702.3M | $21.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.3M | $3.2M | ||
| Q3 25 | $-66.3M | $9.5M | ||
| Q2 25 | $-58.3M | $932.0K | ||
| Q1 25 | $870.1M | $9.1M | ||
| Q4 24 | $-30.0M | $-10.0M | ||
| Q3 24 | $-77.0M | $12.5M | ||
| Q2 24 | $-71.5M | $8.7M | ||
| Q1 24 | $70.8M | $6.9M |
| Q4 25 | $-36.6M | $2.9M | ||
| Q3 25 | $-69.7M | $9.4M | ||
| Q2 25 | $-59.6M | $787.0K | ||
| Q1 25 | $868.4M | $8.7M | ||
| Q4 24 | $-33.8M | $-10.3M | ||
| Q3 24 | $-77.5M | $12.4M | ||
| Q2 24 | $-78.8M | $8.5M | ||
| Q1 24 | $61.2M | $6.6M |
| Q4 25 | -22.3% | 3.1% | ||
| Q3 25 | -33.1% | 10.5% | ||
| Q2 25 | -33.3% | 0.9% | ||
| Q1 25 | 73.8% | 10.1% | ||
| Q4 24 | -15.8% | -10.8% | ||
| Q3 24 | -39.4% | 14.0% | ||
| Q2 24 | -42.2% | 10.0% | ||
| Q1 24 | 29.1% | 7.6% |
| Q4 25 | 1.4% | 0.3% | ||
| Q3 25 | 1.6% | 0.1% | ||
| Q2 25 | 0.7% | 0.2% | ||
| Q1 25 | 0.1% | 0.4% | ||
| Q4 24 | 1.8% | 0.2% | ||
| Q3 24 | 0.3% | 0.1% | ||
| Q2 24 | 4.0% | 0.2% | ||
| Q1 24 | 4.6% | 0.3% |
| Q4 25 | — | 1.07× | ||
| Q3 25 | -4.17× | 20.96× | ||
| Q2 25 | — | — | ||
| Q1 25 | 1.00× | — | ||
| Q4 24 | — | -3.19× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PTCT
Segment breakdown not available.
SCOR
| Transferred Over Time | $77.1M | 83% |
| Research Insight Solutions | $14.6M | 16% |
| Related Party | $2.5M | 3% |
